Abstract. We study the propagation of nucleons and nuclei in tissue-like media within a Monte Carlo Model for Heavy-ion Therapy (MCHIT) based on the GEANT4 toolkit (version 8.2). The model takes into account fragmentation of projectile nuclei and secondary interactions of produced nuclear fragments. Model predictions are validated with available experimental data obtained for water and PMMA phantoms irradiated by monoenergetic carbon-ion beams. The MCHIT model describes well (1) the depth-dose distributions in water and PMMA, (2) the doses measured for fragments of certain charge, (3) the distributions of positron emitting nuclear fragments produced by carbon-ion beams, and (4) the energy spectra of secondary neutrons measured at different angles to the beam direction. Radial dose profiles for primary nuclei and for different projectile fragments are calculated and discussed as possible input for evaluation of biological dose distributions. It is shown that at the periphery of the transverse dose profile close to the Bragg peak the dose from secondary nuclear fragments is comparable to the dose from primary nuclei.
Introduction
Radiation therapy of deep-seated tumors with protons and carbon ions [1] exploits an inverse energy deposition profile for such heavy particles with the Bragg peak at the end of their range in tissues. In this situation a favourable ratio between the maximum dose in tumor volume and the minimum dose in healthy tissues at the entrance path through the patient's body can be provided. An additional advantage of carbon ions stems from their increased biological effectiveness in killing tumor cells close to the Bragg peak [1] . This also helps in sparing healthy tissues beyond the tumor.
High dose gradients can be achieved in carbon-ion radiation therapy. This makes possible a very selective impact on the tumor, but requires thorough treatment planning. This should include reliable calculations of doses from secondary nuclear fragments, which are also highly ionizing particles with increased biological effect. We argue that the GEANT4 toolkit [2] , general-purpose Monte Carlo software for particle transport calculations [3, 4] , can be successfully used for quantifying depth and radial dose profiles for primary and secondary nuclei of therapeutic energies.
MCHIT model
The current version of our Monte Carlo Model for Heavy-ion Therapy (MCHIT) [5, 6] is based on the version 8.2 of the GEANT4 toolkit [2] . Electromagnetic interaction of primary and secondary charged particles is described within a set of models called "standard electromagnetic physics" [3, 4] . Ionization energy loss and straggling of charged particles due to interaction with atomic electrons are taken into account along with multiple Coulomb scattering on atomic nuclei. At each simulation step the energy loss of a charged particle a Presenting author, e-mail: pshenich@fias.uni-frankfurt.de is calculated according to the Bethe-Bloch formula with the mean excitation potential set to 77 eV for water molecules and 68.5 eV for PMMA.
The binary cascade model is used to describe the collisions of energetic hadrons and nuclei with nuclei from the phantom medium [3, 4] . Depending on the collision impact parameter, nuclear remnants of various size and excitation energy are produced in nucleus-nucleus collisions. Evaporation of nucleons, deutrons, tritons, 3 He and 4 He is a dominant deexcitation process at excitation energies of nuclear remnants below 3 MeV per nucleon. The decay of highly excited nuclear remnants is described within the statistical Fermi break-up model. This model is used to describe the explosive decay of light hot fragments up to 16 O with excitation energies above 3 MeV per nucleon [7] . The decay of a nuclear system at high excitation energies is characterized by a great number of open channels. This makes difficult to perform calculations on the basis of analytical formulae and approximations for the fragmentation cross sections which are based only on rather scarce experimental data. Instead, Monte Carlo models for nuclear fragmentation are employed in calculations. MCHIT predictions are verified with the available experimental data on the depth-dose distributions measured in tissue-like phantoms.
In addition to beam particles, electromagnetic and hadronic interactions of secondary particles with phantom material are included in simulations. More details on the physical models employed in MCHIT can be found in refs. [5, 6] 
Validation of MCHIT with experimental data
We consider several characteristics relevant to the transport of a carbon-ion beam in tissue-like media, which complement each other in validating the MCHIT model. Since many characteristics are measured with different experimental techniques, we consider for the MCHIT validation data collected in several experiments. First, the model has confronted with the total depthdose distributions measured in water and PMMA. Then, the doses measured for secondary fragments of different charge, e.g. from hydrogen to boron nuclei, are considered. They give important information on 12 C fragmentation in violent nucleus-nucleus collisions with large overlap of nuclear densities which create hot nuclear systems. The GEANT4 models describing the decay of hot nuclei can be tested with these data. On the other hand, the spatial distributions of nuclear fragments close in mass to the projectile, e.g. 10 C and 11 C, which are measured via their β + -decay, provide information on peripheral nucleus-nucleus collisions. Finally, the energy spectra of secondary neutrons measured at various angles bring complementary information on the nuclear reactions between projectile and target nuclei.
Depth-dose distributions for primary and secondary fragments
The calculated distribution of the total dose in a 15 × 15 × 25 cm polymethylmethacrylate (PMMA) phantom irradiated by 279.23 A MeV 12 C beam is shown in fig. 1 and compared with the experimental data by Matsufuji et al. [8] . The calculations were performed for a Gaussian beam profile of 10 mm FWHM by splitting the phantom into thin slices and calculating the energy deposited in each of the slices per beam particle. The energy spread of the beam was assumed to be Gaussian with the FWHM of 0.2% of the reported beam energy.
The experimental data [8] were normalized to the entrance dose and were superimposed on the calculated depth-dose distribution by shifting the data points in depth by +3.62 mm. We attribute this correction to possible uncertainties in the measurements of the initial beam energy.
The contributions to the total dose in PMMA phantom associated with different fragments were measured at depth of 78 and 112 mm for hydrogen, helium, lithium, beryllium and boron fragments [8] . These fractions were multiplied by the absolute values of calculated dose and plotted in fig. 1 (b) together with MCHIT predictions for each kind of fragment. Only secondary fragments, mainly protons and helium nuclei, propagate beyond the distal edge of the Bragg peak. As their relative biological effectiveness (RBE) [1] differs from the RBE for primary ions, this should be taken into account in calculating biological dose beyond the Bragg peak region.
As shown in fig. 1 , the MCHIT model successfully describes the total dose as well as the sum of doses obtained from fragments other than carbon. The latter accounts for ∼ 20% of the total dose at 78 and 112 mm depth. The contributions from lithium and beryllium fragments are also well described, while the dose from helium and boron fragments are underpredicted, possibly due to underestimation of their yields. Further development of the GEANT4 models for nucleus-nucleus collisions is required to eliminate this disagreement.
Yields of positron-emitting fragments
Nuclear fragments 10 C and 11 C, which have the same charge as 12 C projectiles, are abundantly produced in peripheral nucleus-nucleus collisions. These unstable nuclei are formed via the loss of one or two neutrons and can be detected by their β + -decays accompanied by the positron emission. In addition, 15 O nuclei are also produced from target 16 O nuclei. The annihilation of a positron on an electron of the medium results in the emission of two gamma quanta, which can be registered by means of the positron emission tomography (PET) [9, 10] . This method is used for monitoring of the carbon-ion therapy [1] by comparison of the calculated β + -activity distribution obtained for the prescribed dose with the distribution measured during therapeutic irradiation or soon after it. In experiments with water and PMMA phantoms the evolution of the total β + -activity profile with time can be studied and the contributions from specific β + -emitting nuclei can be extracted [10] .
The depth distributions of positron-emitting nuclei, 10 C, 11 C and 15 O, are shown in fig. 2 as numbers of these nuclei per unit depth and per beam particle. The distributions calculated with MCHIT were convoluted with a Gaussian of 10 mm FWHM to simulate a finite spatial resolution of a PET scanner. The depth distribution of 11 C shows clear correlation with the total depth-dose distribution, which is also shown in fig. 2 . Although the calculated distributions show more sharp peaks compared to the data [10] , the overall agreement is good. The model predicts quite small contributions to the total β + -activity from 10 C and 15 O nuclei, which is in accordance with the experimental findings [10] .
Energy spectra of secondary neutrons
While most of charged particles deposit their energy locally in the region before and at the Bragg peak, energetic neutrons produced in collisions of 12 C projectiles with target nuclei propagate further at large distances from the tumor volume. Therefore, it is important to test the MCHIT model with available experimental data for secondary neutrons, in particular with energy spectra of neutrons measured at different angles [11] . The estimations of the doses from secondary neutrons in proton and heavy ion therapy obtained within the MCHIT model were already given in ref. [5] .
The calculated energy spectra of secondary neutrons which are produced by 200 A MeV 12 C beam in a 12.78-cm thick water phantom are shown in fig. 3. For comparison fig. 3 also shows the spectra of neutrons measured by Gunzert-Marx et al. [11] Experimental data obtained at GSI [11] are shown by points.
nuclei is not equally distributed between the emitted neutrons as they can be emitted at various angles to the beam direction and can have different momenta before the collision due to the Fermi motion in the primary nuclei. For example, some limited fraction of emitted neutrons has velocities exceeding the beam velocity. This is reflected in the exponential fall-off of neutron spectra above the beam energy of 200 MeV. This feature is nicely reproduced by the MCHIT model.
Some discrepancy between the model predictions and the experimental data is found for relatively slow neutrons emitted at larger angles 20 0 and 30 0 . Since such neutrons are mostly produced by neutron evaporation, we conclude that there is still room for improvement of nuclear de-excitation models used in GEANT4.
MCHIT predictions for dose contributions from nuclear fragments
Based on the successful validation of the MCHIT model demonstrated above, one can apply it now for calculating the spatial dose distributions from therapeutic carbon-ion beam, including the contributions from specific secondary particles. For example, the radial dose distributions from nuclear fragments with charges from 1 to 6 calculated for 279 A MeV 12 C beam in PMMA are shown in fig. 4 . The Bragg peak for such energy is located at ∼ 130 mm. The radial dependence of beam intensity in the transverse plane was taken to be Gaussian with FWHM of 10 mm. In fig. 4 the volume energy deposition is presented in MeV/mm 3 per beam particle, and it is calculated for the depth in PMMA from 120 to 130 mm, i.e. in the region of the Bragg peak, see fig. 1 . The radial dose distribution from carbon ions entering into the phantom (for the depths from 0 to 20 mm) is also presented in fig. 4(a) . As shown by calculations, about ∼ 50% of primary ions are lost on their way to the Bragg peak due to nuclear interactions. This reduces the energy deposition from carbon ions in the Bragg peak region. Since only secondary fragments propagate beyond the distal edge of the Bragg peak, the dose there is delivered exclusively by the projectile fragments, mainly hydrogen and helium nuclei, as shown in fig. 1(b) . It is interesting to note that the energy deposition from secondary fragments can not be neglected even in the Bragg peak region. There, the contribution to the total dose due to secondary fragments is about ∼ 10% at the center of the beam profile. However, since the secondary fragments produced in nucleus-nucleus collisions can be emitted at large angles, their radial distributions are much wider compared to 12 C beam nuclei, see fig. 4(b) . Secondary fragments contribute up to ∼ 20% of the total dose at the radii of ∼ 10 mm.
Discussion
According to the MCHIT model, the depth-dose distributions are essentially different for each kind of secondary fragment, both in longitudinal and transverse directions. As the biological effectiveness of heavy ions for therapy essentially depends on the ion charge, mass and energy, the obtained distributions can be used to calculate the depth and lateral profiles of biological doses as well as corresponding cell survival rates.
The accuracy of the pencil-beam approximation, which assumes that the dose at any depth and radius is delivered exclusively by primary beam particles, may be valid for proton beams, where the production of secondary nuclear fragments can be neglected. However, this approximation becomes less accurate for carbon-ion beams, where a noticeable fraction of dose (up to ∼ 20%) is delivered by secondary nuclear fragments. As shown by our calculations of the radial dose profiles for each kind of fragments at the Bragg peak, the largest contribution apart from 12 C projectiles is obtained from helium and boron fragments. New experimental studies of radial dose profiles from heavy-ion beams in tissue-like media, especially with detection of fragment charge, will be of great importance for the purpose of validation of the MCHIT model and development of the GEANT4 toolkit. In turn, this will contribute significantly to the construction of a realistic theoretical model for heavy-ion cancer therapy.
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